retatrutide phase 3 Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized 2a trial Retatrutide Delivers 22.6% Weight Loss

doi: 10.1097/00000478-199003000-00002 10 Aidan CarneyJGordonHCarpenterPCVittal ShenoyBGoVLW

If you have recently started a GLP-1 medication, you may be experiencing the relief of finally seeing the scale move

Multiple treatment rounds (2-5 courses) are often needed, with retesting used to guide further therapy

Application of nano-carbon and titanium clip combined labeling in robot-assisted laparoscopic transverse colon cancer surgery

Patients who are starting GLP-1 treatment for the first time and prefer a needle-free option should note that Direct Meds' sublingual format is currently available for semaglutide only